Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GLB1L2 |
| Upstream (Parents) |
|---|
| (<<) SPINT1 → GLB1L2 |
| (<<) FAM60A → GLB1L2 |
| Downstream (Children) |
|---|
| GLB1L2 → SLC2A1 (>>) |
| GLB1L2 → GAGE12F///GAGE2A///GAGE12J///GAGE12G///GAGE2B///GAGE2E///GAGE12I///GAGE7///GAGE6///GAGE5///GAGE4///GAGE2C///GAGE1 (>>) |
| GLB1L2 → TRIB3 (>>) |
| GLB1L2 → FLJ20712 (>>) |
| GLB1L2 → AXIN1 (>>) |
| GLB1L2 → CD320 (>>) |
| GLB1L2 → SH2D3A (>>) |
| GLB1L2 → ACSL4 (>>) |
| GLB1L2 → DGKZ (>>) |
| GLB1L2 → EFNA3 (>>) |
| GLB1L2 → ZNF185 (>>) |
